The Swiss Life Investment Foundation has successfully completed the opening of the "Real Estate Switzerland Retirement and Healthcare" investment group. Due to high demand, issue volume was increased to a total of CHF 151 million.

With subscriptions of some CHF 330 million (before reductions), the opening of the “Real Estate Switzerland Retirement and Healthcare” investment group in April 2019 has been a great success. In view of the high demand by just under 100 investors and a promising acquisition pipeline, a decision has been reached to increase the original subscription volume of CHF 67 million to a total of CHF 151 million by way of a supplementary offer to the subscribing investors as part of a second opening.

Stephan Thaler, Managing Director of the Swiss Life Investment Foundation, is very pleased: “The success of the opening is a tremendous vote of confidence on the part of our investors in a segment with excellent growth prospects, as well as in the Swiss Life Investment Foundation. The ‘Retirement and Healthcare’ investment group thus has just under CHF 200 million in assets now.”

The additional funds are to be used to purchase two first-class apartment buildings in Zurich’s Seefeld district. The properties in question are multigenerational and feature comprehensive services. In addition to their great location and property quality, they also enjoy a very good rating for senior housing. The acquisition increases the investment group’s diversification and long-term earnings stability.

Attractive retirement and healthcare real estate
The “Real Estate Switzerland Retirement and Healthcare” investment group responds to the demographic trend: life expectancy continues to rise in Switzerland. The share of people over age 80 as a percentage of the overall population will rise from six percent today to 11 percent by 2050, according to the Swiss Federal Statistical Office. In view of this development, the demand for age-appropriate housing is growing as well.

Media contact

Media Relations
Tel.: +41 43 284 77 77

Investor Relations
Tel.: +41 43 284 52 76